(+)-dexrazoxane multiple interactions EXP 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of ANXA10 mRNA CTD PMID:26873546 (E)-thiamethoxam increases expression ISO RGD:1318989 6480464 Thiamethoxam results in increased expression of ANXA10 mRNA CTD PMID:32194361 17beta-estradiol decreases expression ISO RGD:1318989 6480464 Estradiol results in decreased expression of ANXA10 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1318989 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANXA10 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1318989 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA10 mRNA CTD PMID:23625689 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1318989 6480464 2-methyl-2H-pyrazole-3-carboxylic acid 2-methyl-4-o-tolylazophenylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ANXA10 mRNA] CTD PMID:23625689 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1318989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ANXA10 mRNA more ... CTD PMID:28628672 aflatoxin B1 affects expression ISO RGD:1318989 6480464 Aflatoxin B1 affects the expression of ANXA10 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1318989 6480464 Aflatoxin B1 results in decreased methylation of ANXA10 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1318989 6480464 Aflatoxin B1 results in decreased expression of ANXA10 mRNA CTD PMID:22100608 , PMID:27153756 amphibole asbestos increases expression ISO RGD:1318989 6480464 Asbestos, Amphibole results in increased expression of ANXA10 mRNA CTD PMID:20831825 benzo[a]pyrene decreases expression ISO RGD:1318989 6480464 Benzoapyrene results in decreased expression of ANXA10 mRNA CTD PMID:20106945 , PMID:32234424 bisphenol A decreases expression ISO RGD:1560956 6480464 bisphenol A results in decreased expression of ANXA10 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1318989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ANXA10 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:1318989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANXA10 mRNA CTD PMID:28628672 butanal increases expression ISO RGD:1318989 6480464 butyraldehyde results in increased expression of ANXA10 mRNA CTD PMID:26079696 cadmium dichloride increases methylation ISO RGD:1560956 6480464 Cadmium Chloride results in increased methylation of ANXA10 promoter CTD PMID:22457795 carbendazim increases expression ISO RGD:1318989 6480464 carbendazim results in increased expression of ANXA10 mRNA CTD PMID:32194361 carbon nanotube decreases expression ISO RGD:1318989 6480464 Nanotubes, Carbon results in decreased expression of ANXA10 mRNA CTD PMID:24389112 chlorpyrifos increases expression ISO RGD:1318989 6480464 Chlorpyrifos results in increased expression of ANXA10 mRNA CTD PMID:32194361 cisplatin multiple interactions ISO RGD:1318989 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of ANXA10 mRNA CTD PMID:21858171 cyclosporin A decreases expression ISO RGD:1318989 6480464 Cyclosporine results in decreased expression of ANXA10 mRNA CTD PMID:20106945 cyprodinil increases expression ISO RGD:1318989 6480464 cyprodinil results in increased expression of ANXA10 mRNA CTD PMID:32194361 dexamethasone multiple interactions ISO RGD:1318989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ANXA10 mRNA more ... CTD PMID:28628672 difenoconazole increases expression ISO RGD:1318989 6480464 difenoconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 dimethomorph increases expression ISO RGD:1318989 6480464 dimethomorph results in increased expression of ANXA10 mRNA CTD PMID:32194361 doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of ANXA10 mRNA CTD PMID:26873546 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ANXA10 mRNA CTD PMID:26873546 enilconazole increases expression ISO RGD:1318989 6480464 enilconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 epoxiconazole increases expression ISO RGD:1318989 6480464 epoxiconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 ethoprophos increases expression ISO RGD:1318989 6480464 ethoprophos results in increased expression of ANXA10 mRNA CTD PMID:32194361 fenhexamid increases expression ISO RGD:1318989 6480464 N-2, 3-dichloro-4-hydroxyphenyl-1-methylcyclohexanecarboxamide results in increased expression of ANXA10 mRNA CTD PMID:32194361 fludioxonil increases expression ISO RGD:1318989 6480464 fludioxonil results in increased expression of ANXA10 mRNA CTD PMID:32194361 flusilazole increases expression ISO RGD:1318989 6480464 flusilazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 fluxapyroxad increases expression ISO RGD:1318989 6480464 fluxapyroxad results in increased expression of ANXA10 mRNA CTD PMID:32194361 furan increases expression ISO RGD:1560956 6480464 furan results in increased expression of ANXA10 mRNA CTD PMID:27387713 indometacin multiple interactions ISO RGD:1318989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ANXA10 mRNA more ... CTD PMID:28628672 iprodione increases expression ISO RGD:1318989 6480464 iprodione results in increased expression of ANXA10 mRNA CTD PMID:32194361 N-Nitrosopyrrolidine decreases expression ISO RGD:1318989 6480464 N-Nitrosopyrrolidine results in decreased expression of ANXA10 mRNA CTD PMID:32234424 O-methyleugenol decreases expression ISO RGD:1318989 6480464 methyleugenol results in decreased expression of ANXA10 mRNA CTD PMID:32234424 paracetamol decreases expression ISO RGD:1318989 6480464 Acetaminophen results in decreased expression of ANXA10 mRNA CTD PMID:21420995 , PMID:29067470 pentanal increases expression ISO RGD:1318989 6480464 pentanal results in increased expression of ANXA10 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1318989 6480464 perfluorooctane sulfonic acid results in decreased expression of ANXA10 mRNA CTD PMID:27153767 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1318989 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ANXA10 mRNA CTD PMID:16979875 pirinixic acid multiple interactions ISO RGD:1318989 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ANXA10 mRNA CTD PMID:19710929 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ANXA10 mRNA CTD PMID:19710929 piroxicam multiple interactions ISO RGD:1318989 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of ANXA10 mRNA CTD PMID:21858171 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of ANXA10 mRNA CTD PMID:23608068 prochloraz increases expression ISO RGD:1318989 6480464 prochloraz results in increased expression of ANXA10 mRNA CTD PMID:32194361 propanal increases expression ISO RGD:1318989 6480464 propionaldehyde results in increased expression of ANXA10 mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:1318989 6480464 propiconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 silicon dioxide increases expression ISO RGD:1318989 6480464 Silicon Dioxide analog results in increased expression of ANXA10 mRNA CTD PMID:25895662 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ANXA10 mRNA CTD PMID:17350061 sodium arsenite decreases expression ISO RGD:1318989 6480464 sodium arsenite results in decreased expression of ANXA10 mRNA CTD PMID:29301061 sodium dichromate increases expression ISO RGD:1560956 6480464 sodium bichromate results in increased expression of ANXA10 mRNA CTD PMID:22561333 tebuconazole increases expression ISO RGD:1318989 6480464 tebuconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 tetraphene increases expression EXP 6480464 benzaanthracene results in increased expression of ANXA10 mRNA CTD PMID:26377693 thiamethoxam increases expression ISO RGD:1318989 6480464 Thiamethoxam results in increased expression of ANXA10 mRNA CTD PMID:32194361 thiram increases expression ISO RGD:1318989 6480464 Thiram results in increased expression of ANXA10 mRNA CTD PMID:32194361 trichloroethene decreases methylation ISO RGD:1560956 6480464 Trichloroethylene results in decreased methylation of ANXA10 gene CTD PMID:27618143 troglitazone decreases expression ISO RGD:1318989 6480464 troglitazone results in decreased expression of ANXA10 mRNA CTD PMID:25572481 valproic acid decreases expression ISO RGD:1318989 6480464 Valproic Acid results in decreased expression of ANXA10 mRNA CTD PMID:29154799 zinc atom multiple interactions ISO RGD:1318989 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ANXA10 mRNA CTD PMID:16979875 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of ANXA10 mRNA CTD PMID:20857495 zinc atom increases expression ISO RGD:1318989 6480464 Zinc deficiency results in increased expression of ANXA10 mRNA CTD PMID:18356318 zinc(0) multiple interactions ISO RGD:1318989 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ANXA10 mRNA CTD PMID:16979875 zinc(0) increases expression ISO RGD:1318989 6480464 Zinc deficiency results in increased expression of ANXA10 mRNA CTD PMID:18356318 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of ANXA10 mRNA CTD PMID:20857495